Background and Challenge After a major corporate reorganization, the medical operations group of a global pharmaceutical corporation sought new synergies through restructuring while continuing uninterrupted service to its internal and external stakeholders. WLH worked with senior leaders to develop the group’s strategy, design its structure, and identify operational efficiencies. Approach and Deliverables To approach the […]
Over an 18-month period, one of the largest global pharmaceutical companies engaged in a strategic reorganization to help its US sales organization compete in the changing healthcare landscape, post-Affordable Care Act. The client’s decision to move to a regional business-unit structure required clarifying roles and responsibilities for the therapeutic, cluster-based sales teams.
After a major corporate reorganization, the medical operations group of a global pharmaceutical corporation sought new synergies through restructuring while continuing uninterrupted service to its internal and external stakeholders. WLH worked with senior leaders to develop the group’s strategy, design its structure, and identify operational efficiencies.
External marketplace forces and plans to grow the company through product acquisitions encouraged a growing biotech company to evaluate their field organizational structure. The primary goal was to become a more dominant player in a therapeutic area. Through WLH thought partnership, senior leaders decided to create a regional structure that would be more responsive to healthcare ecosystem dynamics.
A major global medical device company reorganized its Marketing function to bring various business unit marketing teams together into one worldwide franchise marketing team. The goal was to strengthen the overall branding, eliminate redundancies, and streamline processes.
External marketplace forces encouraged a leading global specialty pharmaceutical company to evaluate its US Market Access strategy and organizational structure. Internally, the organization was preparing for a series of product launches and new indications. The primary goal was to accelerate access for ground breaking therapies and to enhance the customer experience.
As the healthcare marketplace continues to evolve, many pharmaceutical organizations are reevaluating how their organizational design supports their strategic priorities. Pharmaceutical companies are redesigning field based teams due to restricted access. For many organizations, the redesign provides better service to larger, more organized customers and ensures pull-through at the provider level. Specifically, field force teams […]
To our clients and colleagues, Thank you for the positive responses and feedback we have received from the last two issues of the newsletter. This month’s issue is focused on organizational design and value. As always, we hope these articles provide you with tips and techniques to apply in your organization. WLH Consulting, Inc. is proud […]